Market Access/ News/ News Axsome faces delay for depression drug, hitting shares hard Phil Taylor Axsome Therapeutics, depression, fda 0 Comment The FDA was supposed to be delivering its verdict on Axsome Therapeutics’ depression therapy AXS-05 in less than Share X Axsome faces delay for depression drug, hitting shares hard https://pharmaphorum.com/news/axsome-faces-delay-for-depression-drug-hitting-shares-hard/
